☆ 4.6 Article

Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease

FRONTIERS IN MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Rheumatology

Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

Yukai Wang et al.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

B cell-activating factor and its targeted therapy in autoimmune diseases

Yidan Zhang et al.

Summary: B cells play a pivotal role in autoimmune diseases, and B cell-activating factor (BAFF) is key in driving autoreactive B cell response. Increased BAFF levels have been observed in patients with autoimmune diseases and mouse models where autoantibody production is prominent. Recent clinical studies have shown BAFF as a potential therapeutic target for treating autoimmune diseases.

CYTOKINE & GROWTH FACTOR REVIEWS (2022)

添加到收藏夹

Review Medicine, General & Internal

Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features-What Do We Already Know?

Ewa Miadlikowska et al.

Summary: Interstitial pneumonia with autoimmune features (IPAF) is a type of interstitial lung disease with varied prognosis and course. Currently, there is a lack of specific and sensitive biomarkers for predicting disease progression, monitoring natural history, and stratifying patients for treatment. Several studies have focused on circulating biomarkers and assessed their diagnostic and prognostic value in interstitial lung diseases. However, a meta-analysis of pulmonary fibrosis biomarkers in IPAF is still lacking due to the heterogeneity in research methodology and analyzed groups.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Review Immunology

Targeted Immunotherapy for Autoimmune Disease

Seung Min Jung et al.

Summary: Biological drugs and small molecule inhibitors have become the standard-of-care for treating autoimmune diseases, but there are still challenges in terms of therapeutic efficacy and safety profiles. Emerging therapies using advanced molecular engineering techniques aim to induce immune tolerance and overcome these challenges.

IMMUNE NETWORK (2022)

添加到收藏夹

Review Rheumatology

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Paolo Spagnolo et al.

Summary: This study discusses the different types of interstitial lung diseases (ILDs) and their association with autoimmune and connective tissue diseases (CTDs), as well as introduces drug treatment studies for some fibrosing ILDs. It emphasizes the importance of fibrosis in ILDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Allergy

Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis

Wanlong Wu et al.

Summary: MDA5(+) DM is a rare autoimmune disease predominantly reported in East Asia, characterized by high mortality due to rapid-progressive interstitial lung disease. The prognosis factors and treatment regimens for this disease still require further research.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

添加到收藏夹

Review Rheumatology

10 Years of belimumab experience: What have we learnt?

Roger A. Levy et al.

Summary: Belimumab, as the first biologic approved for SLE, has shown significant efficacy and safety in reducing disease activity and new SLE flares in clinical studies, establishing itself as an important new treatment option for patients with SLE.

LUPUS (2021)

添加到收藏夹

Article Pediatrics

An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus

Vitor Cavalcanti Trindade et al.

Summary: Childhood-onset systemic lupus erythematosus (cSLE) is a complex autoimmune condition characterized by unpredictable flare and high morbidity and mortality rates. Treatment mainly involves antimalarials and glucocorticoids, with newer options such as biologic agents showing promise for future use in pediatric patients. Additionally, management practices for cSLE patients include regular evaluations, vaccinations, physical activity, and addressing mental health issues.

PEDIATRIC DRUGS (2021)

添加到收藏夹

Review Medicine, General & Internal

Belimumab in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease: Case Report and Literature Review

John Mwangi et al.

Summary: ILD is a group of heterogeneous parenchymal lung disorders characterized by inflammation, fibrosis, or scarring of the lung's interstitial, which often leads to dyspnea. It is commonly associated with connective tissue diseases and is a serious pulmonary complication with limited therapeutic options, resulting in significant morbidity. Emerging biologic therapies are being investigated for the treatment of various forms of ILD, such as the use of belimumab in cases associated with systemic lupus erythematosus and scleroderma overlap.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

添加到收藏夹

Review Rheumatology

The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases

Yukai Wang et al.

Summary: Screening and follow-up of interstitial lung disease associated with rheumatoid arthritis (RA-ILD) is challenging in clinical practice due to majority of patients being asymptomatic and lack of optimal tools for early screening. Usual interstitial pneumonia (UIP) is the most frequent radiological and pathological pattern in RA-ILD, indicating poor prognosis and high risk of acute exacerbations and infections. Lung ultrasound (LUS) and serum Krebs von den Lungen-6 antigen (KL-6) have been recognized as sensitive biomarkers for early detection of ILD, showing significant correlation with high-resolution computed tomography (HRCT) and pulmonary function tests (PFTs) in systemic sclerosis-associated ILD (SSc-ILD).

ARTHRITIS RESEARCH & THERAPY (2021)

添加到收藏夹

Review Rheumatology

The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement

Michael Hughes et al.

Summary: Ultrasound technology has been widely used in the study of systemic sclerosis, providing non-invasive and radiation-free insights into the disease. While offering novel perspectives on disease pathogenesis and measurement, there are still unmet needs that must be addressed for ultrasound to play a more central role in the clinical care and research of systemic sclerosis.

JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)

添加到收藏夹

Article Rheumatology

Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study

Ayse Ayzit Kilinc et al.

RHEUMATOLOGY INTERNATIONAL (2020)

添加到收藏夹

Article Rheumatology

Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease

Yukai Wang et al.

RHEUMATOLOGY (2020)

添加到收藏夹

Review Rheumatology

Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?

Muriel Elhai et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

添加到收藏夹

Review Critical Care Medicine

Lung Ultrasound Scanning for Respiratory Failure in Acutely Ill Patients A Review

Seth Koenig et al.

CHEST (2020)

添加到收藏夹

Article Medicine, General & Internal

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Respiratory System

The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease

Anna-Maria Hoffmann-Vold et al.

RESPIRATORY RESEARCH (2020)

添加到收藏夹

Review Rheumatology

Utilize lung ultrasound B-lines and KL-6 to monitor anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a case report and literature review

Yukai Wang et al.

CLINICAL RHEUMATOLOGY (2019)

添加到收藏夹

Article Rheumatology

Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report

A. I. Rebollo Gimenez et al.

LUPUS (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Ultrasound of the Lungs More than a Room with a View

Luna Gargani

HEART FAILURE CLINICS (2019)

添加到收藏夹

Article Dermatology

Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

Takashi Matsushita et al.

JOURNAL OF DERMATOLOGY (2019)

添加到收藏夹

Letter Rheumatology

Imaging and serum biomarkers in connective tissue disease-associated interstitial lung diseases: correlation between lung ultrasound B-lines and KL-6 levels

Yukai Wang et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

添加到收藏夹

Article Critical Care Medicine

Lung Ultrasound: The Emerging Role of Respiratory Therapists

Manjush Karthika et al.

RESPIRATORY CARE (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Inflammation and immunity in IPF pathogenesis and treatment

P. Heukels et al.

RESPIRATORY MEDICINE (2019)

添加到收藏夹

Review Respiratory System

The natural history of progressive fibrosing interstitial lung diseases

Martin Kolb et al.

RESPIRATORY RESEARCH (2019)

添加到收藏夹

Review Rheumatology

The Lung in Rheumatoid Arthritis Focus on Interstitial Lung Disease

Paolo Spagnolo et al.

ARTHRITIS & RHEUMATOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

Takashi Matsushita et al.

SCIENCE ADVANCES (2018)

添加到收藏夹

Article Rheumatology

Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis

Olga Krystufkova et al.

ARTHRITIS RESEARCH & THERAPY (2018)

添加到收藏夹

Review Rheumatology

Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review

YuKai Wang et al.

ARTHRITIS RESEARCH & THERAPY (2017)

添加到收藏夹

Article Rheumatology

Effectiveness of Thoracic Ultrasonography in the Evaluation of the Severity of Pulmonary Involvement in Patients With Systemic Sclerosis

Ebru Cakir Edis et al.

Archives of Rheumatology (2016)

添加到收藏夹

Article Immunology

B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis

Antoine Francois et al.

JOURNAL OF AUTOIMMUNITY (2015)

添加到收藏夹

Review Respiratory System

HRCT of fibrosing lung disease

Joseph Jacob et al.

RESPIROLOGY (2015)

添加到收藏夹

Article Respiratory System

Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease

Tsutomu Hamada et al.

BMC PULMONARY MEDICINE (2015)

添加到收藏夹

Review Rheumatology

Interstitial lung disease in connective tissue disease-mechanisms and management

Athol U. Wells et al.

NATURE REVIEWS RHEUMATOLOGY (2014)

添加到收藏夹

Review Critical Care Medicine

Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease

Francesco Bonella et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

添加到收藏夹

Article Rheumatology

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis

Tatiana Barskova et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

添加到收藏夹

Article Pathology

Pathogenesis of Idiopathic Pulmonary Fibrosis

Paul J. Wolters et al.

Annual Review of Pathology-Mechanisms of Disease (2013)

添加到收藏夹

Article Immunology

Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients

Jianmin Xue et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Article Critical Care Medicine

International evidence-based recommendations for point-of-care lung ultrasound

Giovanni Volpicelli et al.

INTENSIVE CARE MEDICINE (2012)

添加到收藏夹

Article Medicine, General & Internal

Interstitial lung disease in connective tissue disorders

Aryeh Fischer et al.

LANCET (2012)

添加到收藏夹

Review Respiratory System

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases

Nobuhisa Ishikawa et al.

RESPIRATORY INVESTIGATION (2012)

添加到收藏夹

Article Medicine, General & Internal

Idiopathic pulmonary fibrosis

Talmadge E. King et al.

LANCET (2011)

添加到收藏夹

Article Rheumatology

Utility of a simplified ultrasound assessment to assess interstitial pulmonary fibrosis in connective tissue disorders - preliminary results

Marwin Gutierrez et al.

ARTHRITIS RESEARCH & THERAPY (2011)

添加到收藏夹

Article Rheumatology

Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis

Luna Gargani et al.

RHEUMATOLOGY (2009)

添加到收藏夹

Article Critical Care Medicine

Ultrasound in the management of thoracic disease

Daniel A. Lichtenstein

CRITICAL CARE MEDICINE (2007)

添加到收藏夹

Article Medicine, General & Internal

Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases

H. Satoh et al.

JOURNAL OF INTERNAL MEDICINE (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.